TERESA EKLOF: Open Payments
NPI 1124567748 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 17 payments from 10 companies in 2025. Trend: 2023 $627 · 2024 $998 · 2025 $720
Food & beverage: $624Education: $96
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $248 |
| Incyte Corporation | 2 | $133 |
| SEAGEN INC. | 1 | $80 |
| GlaxoSmithKline, LLC. | 1 | $74 |
| Legend Biotech USA Inc. | 3 | $69 |
| PFIZER INC. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Blueprint Medicines Corporation | 1 | $21 |
| Geron Corporation | 1 | $19 |
| BeOne Medicines USA, Inc. | 1 | $15 |
Products named: RYBREVANT, JAKAFI, DARZALEX, CARVYKTI, ELREXFIO, Cresemba, AYVAKIT, RYTELO.
Industry payments across FL — which companies pay providers there.
